Tower Research Capital (TRC)’s TrovaGene, Inc. - Unit TROVU Stock Holding History

Tower Research Capital (TRC)’s Portfolio TROVU Stock Details TROVU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-245	Closed	-$1K	–	4011
2017 Q1	$1K	Buy	+245	New	+$1.02K	﹤0.01%	2946

Tower Research Capital (TRC)'s TROVU Position: Q2 2017 in Review

Tower Research Capital (TRC) sold out of TrovaGene, Inc. - Unit (TROVU) in Q2 2017, closing a stake of 245 shares — an estimated $1K sold.

Tower Research Capital (TRC) first reported a position in TROVU in Q1 2017 and held it in 1 quarter. The position peaked at $1K in Q1 2017. 0 funds tracked by Wall St. Rank hold TROVU as of Q2 2017.

Tower Research Capital (TRC) reported no remaining TrovaGene, Inc. - Unit position as of Q2 2017 after selling out during the quarter.
Tower Research Capital (TRC) sold 245 TrovaGene, Inc. - Unit shares in Q2 2017, an estimated $1K.
Tower Research Capital (TRC) first reported a position in TrovaGene, Inc. - Unit in Q1 2017 and held it in 1 quarter.
Tower Research Capital (TRC)'s TrovaGene, Inc. - Unit position peaked at $1K in Q1 2017.
0 funds tracked by Wall St. Rank held TrovaGene, Inc. - Unit as of Q2 2017.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2017, filed 15 Aug 2017.